- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Merck Serono’s UK press release on FIRE-3 claimed Erbitux extended survival by 7.5 months. PMCPA found the headline, subgroup framing and “paradigm…
A member of the public alleged Servier had not disclosed Valdoxan trial results on time. The PMCPA found multiple breaches of Clause…
A prescribing adviser complained about proposed Procoralan samples and provision of heart rate monitors. Samples weren’t supplied (no breach), but an email…
A sevoflurane packaging “drop test” leaflet was deemed promotional. It omitted cost, adverse event reporting statement and date of preparation/revision, breaching Clauses…
A health professional alleged Chiesi’s exhibition stand at a restaurant meeting was visible to the public. The Panel found no evidence of…
Anonymous complaint alleged off-label promotion of COPD inhalers for exacerbation reduction. Panel found some materials acceptable in context, but ruled breaches where…
A GI nursing journal ad for Cleen and CitraFleet overstated “remarkable events”, implied ESGE guideline support, used an unjustified “lowest volume” superlative,…
Anonymous oncology nurse alleged a Merck Serono rep repeatedly pressured staff to opt into email/text communications. Panel found insufficient evidence on balance…
Esmya patient leaflet warned only against “oral contraceptives”, omitting other hormonal methods. PMCPA ruled it misleading with patient-safety implications; corrective statement and…
A hospital doctor challenged A Menarini’s website governance. PMCPA found failures to certify, recertify and retain certificates for public/patient material, plus Clause…
A hospital consultant received a Qtern promotional email via a third-party network without valid prior permission. The Panel also found the email…
Celgene self-reported Code breaches after a third-party aesthetics company emailed Otezla meeting invites to a 3,000-person database (up to 50% non-HCPs), altered…
GSK challenged a Takeda Actos mailer that mentioned Competact without stating its insulin contraindication. Panel found breaches, but Appeal Board ruled the…
A GP alleged a Roche rep offered a Christmas lunch for a primary care team (a social meeting). Panel found no evidence…
Takeda challenged a GSK Avandia press release on gsk.com as UK-directed internet promotion. The Panel found it did not specifically refer to…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.